Lisa Mayne is a Senior Clinical Trial Oversight Lead at Alnylam Pharmaceuticals, with a background in clinical research and trial management. Lisa has experience working with various organizations in the healthcare industry, including Syneos Health and University Hospitals Bristol NHS Foundation Trust. Lisa holds a Doctorate in Biomedical Sciences from the University of the West of England and has a strong educational background in genetics and molecular pathology. Throughout their career, Lisa has received several awards for their contributions to clinical research and oncology studies. Lisa is also actively involved in mentoring, mental health advocacy, and providing oversight for clinical trials to ensure compliance and quality.
January, 2022 - present
September, 2019